Senior Vice President, Program Leadership

15+ years of progressive experience in biotech or pharma, with a strong focus on drug development

Demonstrated track record of driving programs from Phase 3 through regulatory approval — ideally multiple times across both pharma and biotech settings

Experience building and structuring program governance, decision-making frameworks, and planning processes — not just executing within existing systems

Proven success in launch readiness as an integrated part of late-stage development

Experience leading and elevating cross-functional program teams

Track record of success in general medicine therapeutic areas (cardiovascular, diabetes, endocrinology, metabolic disease, or similar); oncology-only backgrounds are less preferred

The Senior Vice President, Program Leadership serves as the senior-most executive accountable for driving biopharmaceutical programs from late-stage development through regulatory approval and launch readiness.

The Senior Vice President will build and implement robust systems and structure for decision-making and planning, ensure the right people contribute to critical decisions at the right time, and elevate the program leadership and program management function to prepare for NDA submission and commercial.

Own end-to-end program leadership for late-stage assets from Phase 3 through regulatory approval and launch readiness

Drive integrated program strategy, cross-functional alignment, and milestone execution across development, regulatory, CMC, and commercial readiness

Maintain a clear-eyed view of risk, timelines, and dependencies; proactively surface issues and drive resolution

Lead development strategy for programs in Phase 3, with a deep understanding of clinical, regulatory, and CMC interdependencies